Kuros Biosciences is a Swiss-headquartered global innovation company specializing in biologic technologies for spinal fusion. They are committed to discovering, developing, and delivering innovative products such as MagnetOs, a unique bone graft that facilitates bone growth even in soft tissues through their NeedleGrip surface technology. The company has a strong scientific foundation with over 150 years of combined research experience, and its commercial and research activities span three continents, covering more than 20 markets. Kuros Biosciences also leads Project Fusion, a global research initiative that integrates scientific, pre-clinical, and clinical studies to improve spine surgery outcomes.